Know Cancer

or
forgot password
  • cancer clinical trials in alabama

  • Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
    University Of Alabama-Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Hydroxychloroquine, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Birmingham, Alabama 35209
    Neoplasms, Breast, Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Birmingham Hematology and Oncology
    Birmingham, Alabama 35235
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Birmingham Hematology and Oncology
    Birmingham, Alabama 35235
    Breast Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lung Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Northwest Alabama Cancer Center, PC - Muscle Shoals
    Muscle Shoals, Alabama 35661
    Breast Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    UAB Comprehensive Cancer Center

    Trial Locations
    UAB Comprehensive Cancer Center
    University of South Alabama Mitchell Cancer Institute
    Neuroblastoma
    Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
    University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2)
    Mobile, Alabama 36688
    Advanced Neuroendocrine Tumors
    Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    Southern Cancer Center
    Mobile, Alabama 36608
    Multiple Myeloma
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    University of South Alabama Mitchell Cancer Institute
    Mobile, Alabama 36604
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Regional Medical Center

    Trial Locations
    Regional Medical Center
    Clearview Cancer Institute
    Leukemia
    Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer, Cancer of the Breast, Breast Neoplasm
    Patients With Advanced Non-Small Cell Lung Cancer
    Clearview Cancer Institute Oncology Specialties, P.C.
    Huntsville, Alabama 35805
    Non-Small Cell Lung Carcinoma
    Lapatinib and Trastuzumab With or Without Endocrine Therapy
    UAB Cancer Center
    Birmingham, Alabama 35294
    Breast Cancer
    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Extraocular Retinoblastoma
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    UAB Comprehensive Cancer Center

    Trial Locations
    UAB Comprehensive Cancer Center
    University of South Alabama Mitchell Cancer Institute
    Neuroblastoma
    UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
    University of Alabama Birmingham
    Birmingham, Alabama 35233
    Recurrent Respiratory Papillomatosis
    A Study of Spinal Radiosurgery
    University of Alabama at Birmingham/The Kirklin Clinic at Acton Road
    Birmingham, Alabama 35233
    Neoplasm, Arteriovenous Malformations
    Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Cancer, Brain Metastases
    Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia
    UAB Division of Otolaryngology
    Birmingham, Alabama 35233
    Head and Neck Cancer
    Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Pancreatic Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    University of South Alabama Mitchell Cancer Institute

    Trial Locations
    University of South Alabama Mitchell Cancer Institute
    Providence Hospital
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Providence Hospital
    Mobile, Alabama 36608
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Providence Hospital
    Mobile, Alabama 36608
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Northeast Alabama Medical Center
    Anniston, Alabama 36207
    Non-Small Cell Lung Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Clearview Cancer Institute-Decatur
    Clearview Cancer Institute
    Clearview Cancer Institute- Huntsville
    Breast Cancer
    Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Aspergillosis, Invasive Fungal Infections
    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
    A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
    The University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Neurofibromatosis Type 1
    Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Invasive Breast Cancer
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Alabama Clinical Therapeutics, Llc

    Trial Locations
    Alabama Clinical Therapeutics, Llc
    Horizon Research Group, Inc.
    Venous Thrombosis
    Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Non-Small Cell Lung Cancer
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Human Immunodeficiency Virus
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Providence Hospital
    Mobile, Alabama 36608
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Colorectal Cancer
    Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Non Small Cell Lung Cancer